PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
14-Dec-2022 Eurosets Announces First Patient Treated With Colibrì, the Lightest Extracorporeal Life Support System Businesswire
14-Dec-2022 Dermaliq Therapeutics Announces First Participant Randomized in Phase 1b/2 Trial Evaluating DLQ01 Solution for Treatment of Androgenic Alopecia Businesswire
14-Dec-2022 Worldcom Public Relations Group Expands LATAM Region Welcomes Honduras Agency Estrategia Relaciones Públicas Businesswire
14-Dec-2022 physIQ’s eVO2Max™ demonstrates breakout ability to estimate cardiopulmonary functional capacity from wearable sensor data during daily routine activity Businesswire
14-Dec-2022 AdaCore Collaborates with Synopsys to Offer Ada Static Analysis Solution to Coverity Customers Businesswire
14-Dec-2022 Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Report 2022: Gain an Understanding and Analysis of How and Why Companies Enter Joint Venture Deals - ResearchAndMarkets.com Businesswire
14-Dec-2022 Global Musculoskeletal Partnering Deal Trends, Players and Financials Analysis Report 2022 with Directory of Deals Signed by the World's Pharmaceutical and Biotechnology Companies - ResearchAndMarkets.com Businesswire
14-Dec-2022 AI Proteins Expands Executive Team with Hire of Industry Veteran Wendy Dwyer as Chief Business Officer Businesswire
14-Dec-2022 Cytotoxic Drugs and HPAPI Manufacturing Market Research Report 2022 - Industry Trends and Global Forecasts to 2035 - ResearchAndMarkets.com Businesswire
14-Dec-2022 Global Digital Transformation Markets Analysis Report 2022: Everything-as-a-Service (XaaS), Hyperautomation, Low-Code Development Platforms Coming to the Fore - Forecasts to 2027 - ResearchAndMarkets.com Businesswire
14-Dec-2022 Takeda annonce l'acquisition de l'inhibiteur NDI-034858 oral allostérique de TYK2 de Nimbus Therapeutics, un inhibiteur de stade avancé et potentiellement meilleur de sa catégorie Businesswire
14-Dec-2022 Harrow Announces Proposed Offering of $100 Million of Senior Notes Due 2027 and “BB” Rating from Egan-Jones Businesswire
14-Dec-2022 Harrow Prices $25 Million Offering Businesswire
14-Dec-2022 Harrow Enters into Agreement to Acquire Exclusive U.S. Rights to ILEVRO®, NEVANAC®, VIGAMOX®, MAXIDEX®, and TRIESENCE® Businesswire
14-Dec-2022 Insights on the Amyotrophic Lateral Sclerosis Treatment Global Market to 2029 - Rising Awareness and Incidence of ALS is Driving Growth - ResearchAndMarkets.com Businesswire
14-Dec-2022 Global Freeze-drying Market Analysis to 2029 - Featuring SP Industries, Shanghai Tofflon Science Technology, HOF Enterprise and Azbil Among Others - ResearchAndMarkets.com Businesswire
14-Dec-2022 Worldwide Histology and Cytology Industry Report to 2029 - by Type, Product, End-use and Region - ResearchAndMarkets.com Businesswire
14-Dec-2022 Insights on the Agricultural Biotechnology Global Market to 2029 - Rising Demand for Novel Breeding Methods is Driving Growth - ResearchAndMarkets.com Businesswire
14-Dec-2022 Global Metabolomics Market Analysis Report to 2029 - Featuring Thermo Fisher Scientific, Agilent Technologies, Waters and Danaher Among Others - ResearchAndMarkets.com Businesswire
14-Dec-2022 Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements Businesswire